Annual SGA
$41.48 M
+$8.77 M+26.82%
December 1, 2024
Summary
- As of March 13, 2025, FENC annual SGA is $41.48 million, with the most recent change of +$8.77 million (+26.82%) on December 1, 2024.
- During the last 3 years, FENC annual SGA has risen by +$29.24 million (+238.83%).
- FENC annual SGA is now at all-time high.
Performance
FENC SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$8.14 M
-$2.58 M-24.08%
December 1, 2024
Summary
- As of March 13, 2025, FENC quarterly SGA is $8.14 million, with the most recent change of -$2.58 million (-24.08%) on December 1, 2024.
- Over the past year, FENC quarterly SGA has dropped by -$3.40 million (-29.44%).
- FENC quarterly SGA is now -29.44% below its all-time high of $11.54 million, reached on June 30, 2024.
Performance
FENC Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$855.38 M
-$70.00 K-0.01%
December 1, 2024
Summary
- As of March 13, 2025, FENC TTM SGA is -$855.38 million, with the most recent change of -$70.00 thousand (-0.01%) on December 1, 2024.
- Over the past year, FENC TTM SGA has dropped by -$896.02 million (-2204.67%).
- FENC TTM SGA is now -21173.88% below its all-time high of -$4.02 million.
Performance
FENC TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
FENC Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.8% | -29.4% | -2204.7% |
| 3 y3 years | +238.8% | +3.9% | -3029.1% |
| 5 y5 years | +460.4% | +3.9% | -3029.1% |
FENC Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +238.8% | -29.4% | +286.0% | -23.6% | +0.5% |
| 5 y | 5-year | at high | +460.4% | -29.4% | +286.0% | -53.6% | +0.5% |
| alltime | all time | at high | +6653.3% | -29.4% | >+9999.0% | <-9999.0% | +0.5% |
Fennec Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $41.48 M(+26.8%) | $8.14 M(-24.1%) | $41.48 M(-6.1%) |
| Sep 2024 | - | $10.72 M(-7.1%) | $44.17 M(+8.7%) |
| Jun 2024 | - | $11.54 M(+4.1%) | $40.64 M(+10.0%) |
| Mar 2024 | - | $11.08 M(+2.3%) | $36.94 M(+12.9%) |
| Dec 2023 | $32.71 M(+59.5%) | $10.84 M(+50.7%) | $32.71 M(+11.5%) |
| Sep 2023 | - | $7.19 M(-8.2%) | $29.34 M(+0.5%) |
| Jun 2023 | - | $7.83 M(+14.4%) | $29.20 M(+15.7%) |
| Mar 2023 | - | $6.85 M(-8.3%) | $25.25 M(+23.1%) |
| Dec 2022 | $20.51 M(+67.5%) | $7.47 M(+5.9%) | $20.51 M(+22.6%) |
| Sep 2022 | - | $7.05 M(+81.9%) | $16.72 M(+32.7%) |
| Jun 2022 | - | $3.88 M(+83.9%) | $12.60 M(+6.4%) |
| Mar 2022 | - | $2.11 M(-42.8%) | $11.84 M(-3.3%) |
| Dec 2021 | $12.24 M(-5.5%) | $3.68 M(+25.7%) | $12.24 M(+12.8%) |
| Sep 2021 | - | $2.93 M(-6.1%) | $10.85 M(-12.6%) |
| Jun 2021 | - | $3.12 M(+24.5%) | $12.41 M(-4.6%) |
| Mar 2021 | - | $2.51 M(+9.3%) | $13.02 M(+0.5%) |
| Dec 2020 | $12.95 M(+75.0%) | $2.29 M(-48.9%) | $12.95 M(-1.4%) |
| Sep 2020 | - | $4.49 M(+20.6%) | $13.14 M(+35.2%) |
| Jun 2020 | - | $3.72 M(+52.5%) | $9.71 M(+10.0%) |
| Mar 2020 | - | $2.44 M(-1.6%) | $8.84 M(+19.4%) |
| Dec 2019 | $7.40 M(+37.0%) | $2.48 M(+132.3%) | $7.40 M(+17.4%) |
| Sep 2019 | - | $1.07 M(-62.4%) | $6.30 M(+0.3%) |
| Jun 2019 | - | $2.84 M(+181.9%) | $6.29 M(+18.4%) |
| Mar 2019 | - | $1.01 M(-27.0%) | $5.31 M(-1.7%) |
| Dec 2018 | $5.40 M(+7.7%) | $1.38 M(+31.6%) | $5.40 M(-4.4%) |
| Sep 2018 | - | $1.05 M(-43.8%) | $5.65 M(-10.2%) |
| Jun 2018 | - | $1.87 M(+69.4%) | $6.29 M(+12.9%) |
| Mar 2018 | - | $1.10 M(-32.4%) | $5.57 M(+11.1%) |
| Dec 2017 | $5.01 M(+109.0%) | $1.63 M(-3.8%) | $5.01 M(+15.1%) |
| Sep 2017 | - | $1.69 M(+47.8%) | $4.36 M(+39.9%) |
| Jun 2017 | - | $1.15 M(+109.9%) | $3.12 M(+22.8%) |
| Mar 2017 | - | $546.00 K(-43.8%) | $2.54 M(+5.8%) |
| Dec 2016 | $2.40 M(+46.8%) | $972.00 K(+115.0%) | $2.40 M(+25.8%) |
| Sep 2016 | - | $452.00 K(-20.4%) | $1.91 M(+11.8%) |
| Jun 2016 | - | $568.00 K(+39.6%) | $1.71 M(+4.5%) |
| Mar 2016 | - | $407.00 K(-15.2%) | $1.63 M(-0.1%) |
| Dec 2015 | $1.63 M(-35.2%) | $480.00 K(+92.0%) | $1.63 M(-8.2%) |
| Sep 2015 | - | $250.00 K(-49.5%) | $1.78 M(-13.6%) |
| Jun 2015 | - | $495.00 K(+21.0%) | $2.06 M(-15.0%) |
| Mar 2015 | - | $409.00 K(-34.7%) | $2.42 M(-3.8%) |
| Dec 2014 | $2.52 M(+88.9%) | $626.00 K(+17.9%) | $2.52 M(+13.5%) |
| Sep 2014 | - | $531.00 K(-38.1%) | $2.22 M(+13.0%) |
| Jun 2014 | - | $858.00 K(+69.9%) | $1.96 M(+32.8%) |
| Mar 2014 | - | $505.00 K(+54.9%) | $1.48 M(+11.0%) |
| Dec 2013 | $1.33 M(-13.7%) | $326.00 K(+18.5%) | $1.33 M(-15.0%) |
| Sep 2013 | - | $275.00 K(-26.3%) | $1.57 M(+0.1%) |
| Jun 2013 | - | $373.00 K(+3.9%) | $1.57 M(-1.1%) |
| Mar 2013 | - | $359.00 K(-36.1%) | $1.58 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $1.54 M(-20.5%) | $562.00 K(+105.9%) | $1.54 M(+12.0%) |
| Sep 2012 | - | $273.00 K(-30.0%) | $1.38 M(-14.4%) |
| Jun 2012 | - | $390.00 K(+21.9%) | $1.61 M(+3.3%) |
| Mar 2012 | - | $320.00 K(-19.2%) | $1.56 M(-19.8%) |
| Dec 2011 | $1.94 M(-50.1%) | $396.00 K(-21.6%) | $1.95 M(-6.3%) |
| Sep 2011 | - | $505.00 K(+49.4%) | $2.08 M(-12.7%) |
| Jun 2011 | - | $338.00 K(-52.1%) | $2.38 M(-45.9%) |
| Mar 2011 | - | $706.00 K(+34.0%) | $4.40 M(+12.9%) |
| Dec 2010 | $3.90 M(+220.9%) | $527.00 K(-34.7%) | $3.90 M(+17.8%) |
| Sep 2010 | - | $807.00 K(-65.8%) | $3.31 M(+18.4%) |
| Jun 2010 | - | $2.36 M(+1062.1%) | $2.79 M(+274.9%) |
| Mar 2010 | - | $203.00 K(-427.4%) | $745.00 K(-38.7%) |
| Dec 2009 | $1.21 M(-65.5%) | -$62.00 K(-121.2%) | $1.22 M(-47.6%) |
| Sep 2009 | - | $293.00 K(-5.8%) | $2.32 M(-7.4%) |
| Jun 2009 | - | $311.00 K(-53.8%) | $2.50 M(-20.1%) |
| Mar 2009 | - | $673.00 K(-35.4%) | $3.13 M(-11.0%) |
| Dec 2008 | $3.52 M(+7.4%) | $1.04 M(+118.0%) | $3.52 M(+15.8%) |
| Sep 2008 | - | $478.00 K(-49.1%) | $3.04 M(-13.8%) |
| Jun 2008 | - | $939.00 K(-11.5%) | $3.53 M(+4.3%) |
| Mar 2008 | - | $1.06 M(+89.1%) | $3.38 M(+3.1%) |
| Dec 2007 | $3.28 M(+13.7%) | $561.00 K(-41.9%) | $3.28 M(-5.5%) |
| Sep 2007 | - | $966.00 K(+21.8%) | $3.47 M(+9.2%) |
| Jun 2007 | - | $793.00 K(-17.2%) | $3.18 M(+2.7%) |
| Mar 2007 | - | $958.00 K(+27.4%) | $3.09 M(+7.3%) |
| Dec 2006 | $2.88 M(-9.4%) | $752.00 K(+11.7%) | $2.88 M(+5.9%) |
| Sep 2006 | - | $673.00 K(-5.3%) | $2.72 M(-9.9%) |
| Jun 2006 | - | $711.00 K(-4.8%) | $3.02 M(-5.9%) |
| Mar 2006 | - | $747.00 K(+26.4%) | $3.21 M(+0.9%) |
| Dec 2005 | $3.18 M(-8.9%) | $591.10 K(-39.2%) | $3.18 M(+22.8%) |
| Sep 2005 | - | $972.90 K(+8.1%) | $2.59 M(-9.8%) |
| Jun 2005 | - | $900.00 K(+25.3%) | $2.87 M(-15.8%) |
| Mar 2005 | - | $718.00 K(-42.7%) | $3.41 M(-20.7%) |
| Sep 2004 | - | $1.25 M(-12.9%) | $4.30 M(+23.1%) |
| Jun 2004 | $3.49 M(+56.1%) | $1.44 M(+55.0%) | $3.49 M(+11.6%) |
| Mar 2004 | - | $928.60 K(+36.7%) | $3.13 M(+8.5%) |
| Dec 2003 | - | $679.20 K(+52.4%) | $2.88 M(+17.4%) |
| Sep 2003 | - | $445.70 K(-58.5%) | $2.46 M(+11.5%) |
| Jun 2003 | $2.24 M(+88.9%) | $1.08 M(+57.0%) | $2.20 M(+32.2%) |
| Mar 2003 | - | $684.70 K(+171.3%) | $1.67 M(+40.7%) |
| Dec 2002 | - | $252.40 K(+31.5%) | $1.19 M(+4.7%) |
| Sep 2002 | - | $191.90 K(-64.3%) | $1.13 M(-4.4%) |
| Jun 2002 | $1.18 M(+60.3%) | $538.20 K(+165.5%) | $1.18 M(+83.4%) |
| Mar 2002 | - | $202.70 K(+1.9%) | $645.20 K(+45.8%) |
| Dec 2001 | - | $198.90 K(-18.3%) | $442.50 K(-4.5%) |
| Sep 2001 | - | $243.60 K(+10.8%) | $463.40 K(+110.8%) |
| Jun 2001 | $738.70 K(+20.3%) | - | - |
| Dec 2000 | - | $219.80 K | $219.80 K |
| Jun 2000 | $614.20 K | - | - |
FAQ
- What is Fennec Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual SGA year-on-year change?
- What is Fennec Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly SGA year-on-year change?
- What is Fennec Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals TTM SGA year-on-year change?
What is Fennec Pharmaceuticals annual SGA?
The current annual SGA of FENC is $41.48 M
What is the all time high annual SGA for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual SGA is $41.48 M
What is Fennec Pharmaceuticals annual SGA year-on-year change?
Over the past year, FENC annual SGA has changed by +$8.77 M (+26.82%)
What is Fennec Pharmaceuticals quarterly SGA?
The current quarterly SGA of FENC is $8.14 M
What is the all time high quarterly SGA for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly SGA is $11.54 M
What is Fennec Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, FENC quarterly SGA has changed by -$3.40 M (-29.44%)
What is Fennec Pharmaceuticals TTM SGA?
The current TTM SGA of FENC is -$855.38 M
What is the all time high TTM SGA for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high TTM SGA is -$4.02 M
What is Fennec Pharmaceuticals TTM SGA year-on-year change?
Over the past year, FENC TTM SGA has changed by -$896.02 M (-2204.67%)